Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Additionally, serum phosphorus levels were found to be inversely associated with BMD levels. 25(OH)D levels were similar across the three BMD groups, with no significant between-group difference.

Source: Baseline characteristics of patients with CHB. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This cross-sectional study recruited 362 untreated patients with CHB (men aged ≥50 years and postmenopausal women) who underwent both HBV DNA testing and dual-energy X-ray absorptiometry (DXA) within a 6-week interval.

Source: Abstract.

This cross-sectional study recruited 362 untreated patients with CHB (men aged ≥50 years and postmenopausal women) who underwent both HBV DNA testing and dual-energy X-ray absorptiometry (DXA) within a 6-week interval.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Association between HBV DNA levels and bone mineral density in antiviral-naive chronic hepatitis B patients

Cross-sectional study · Frontiers in Endocrinology · 2026

Original publication title

Association between HBV DNA levels and bone mineral density in antiviral-naive chronic hepatitis B patients

Xinyu Zhou; Xue Jing; Na Zu; Zhanghao Li; Xinjuan Kong; Shijin Wang

Copyright © 2026 Zhou, Jing, Zu, Li, Kong and Wang.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Higher HBV DNA levels are independently associated with lower BMD and demonstrate discriminatory ability for osteoporosis status in patients with CHB. Longitudinal studies are warranted to determine the predictive value of HBV DNA in predicting osteoporosis risk.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

Recent studies have shown that patients with chronic hepatitis B (CHB) have an increased prevalence of osteoporosis. However, the direct relationship between hepatitis B virus (HBV) DNA (representing the viral replication level) and bone mineral density (BMD) remains undefined. We aimed to investigate the association between HBV DNA levels and BMD in middle-aged and elderly CHB patients without prior antiviral therapy.

Source: Objectives

Abstract: What methods does the paper describe?

This cross-sectional study recruited 362 untreated patients with CHB (men aged ≥50 years and postmenopausal women) who underwent both HBV DNA testing and dual-energy X-ray absorptiometry (DXA) within a 6-week interval. Based on bone mineral status, patients were categorized into three groups: normal BMD, osteopenia, and osteoporosis. Multiple regression and generalized additive models (GAMs) were applied to analyze associations between HBV DNA and BMD, whereas Receiver operating characteristic (ROC) curve analysis was employed to evaluate the discriminatory ability of HBV DNA levels to distinguish patients with osteoporosis.

Exploratory mediation analysis of β-CTX and CRP was performed to assess indirect statistical associations linking HBV DNA with BMD.

Source: Methods

Abstract: Results

Patients with osteoporosis had considerably higher HBV DNA levels than those with osteopenia or normal BMD. In multivariable analyses, each 1 log10 IU/mL increase in HBV DNA was associated with a 0.22-unit decrease in BMD T-score in the total cohort, with a stronger inverse association observed in males (β = −0.32) than in postmenopausal females (β = −0.16). GAMs revealed a continuous negative association between HBV DNA levels and BMD across the spectrum from normal bone density to osteoporosis (P for trend <0.001).

HBV DNA demonstrated good between-group discriminatory ability for differentiating osteoporosis, with superior accuracy in males (area under the ROC curve = 0.847; optimal cut-off: 2.857 log10 IU/mL). Exploratory mediation analyses suggested that β-CTX and CRP may contribute to the association between HBV DNA and BMD in the total cohort; however, only β-CTX demonstrated a notable mediating effect in males. Notably, the direct association between HBV DNA levels and BMD remained evident across all mediating models.

Source: Results

Abstract: Conclusion

Higher HBV DNA levels are independently associated with lower BMD and demonstrate discriminatory ability for osteoporosis status in patients with CHB. Longitudinal studies are warranted to determine the predictive value of HBV DNA in predicting osteoporosis risk.

Source: Conclusion
Authors’ abstract

Objectives

Recent studies have shown that patients with chronic hepatitis B (CHB) have an increased prevalence of osteoporosis. However, the direct relationship between hepatitis B virus (HBV) DNA (representing the viral replication level) and bone mineral density (BMD) remains undefined. We aimed to investigate the association between HBV DNA levels and BMD in middle-aged and elderly CHB patients without prior antiviral therapy.

Methods

This cross-sectional study recruited 362 untreated patients with CHB (men aged ≥50 years and postmenopausal women) who underwent both HBV DNA testing and dual-energy X-ray absorptiometry (DXA) within a 6-week interval. Based on bone mineral status, patients were categorized into three groups: normal BMD, osteopenia, and osteoporosis. Multiple regression and generalized additive models (GAMs) were applied to analyze associations between HBV DNA and BMD, whereas Receiver operating characteristic (ROC) curve analysis was employed to evaluate the discriminatory ability of HBV DNA levels to distinguish patients with osteoporosis.

Exploratory mediation analysis of β-CTX and CRP was performed to assess indirect statistical associations linking HBV DNA with BMD.

Results

Patients with osteoporosis had considerably higher HBV DNA levels than those with osteopenia or normal BMD. In multivariable analyses, each 1 log10 IU/mL increase in HBV DNA was associated with a 0.22-unit decrease in BMD T-score in the total cohort, with a stronger inverse association observed in males (β = −0.32) than in postmenopausal females (β = −0.16). GAMs revealed a continuous negative association between HBV DNA levels and BMD across the spectrum from normal bone density to osteoporosis (P for trend <0.001).

HBV DNA demonstrated good between-group discriminatory ability for differentiating osteoporosis, with superior accuracy in males (area under the ROC curve = 0.847; optimal cut-off: 2.857 log10 IU/mL). Exploratory mediation analyses suggested that β-CTX and CRP may contribute to the association between HBV DNA and BMD in the total cohort; however, only β-CTX demonstrated a notable mediating effect in males. Notably, the direct association between HBV DNA levels and BMD remained evident across all mediating models.

Conclusion

Higher HBV DNA levels are independently associated with lower BMD and demonstrate discriminatory ability for osteoporosis status in patients with CHB. Longitudinal studies are warranted to determine the predictive value of HBV DNA in predicting osteoporosis risk.

Publication and source details

Original title: Association between HBV DNA levels and bone mineral density in antiviral-naive chronic hepatitis B patients

Xinyu Zhou; Xue Jing; Na Zu; Zhanghao Li; Xinjuan Kong; Shijin Wang

Frontiers in Endocrinology · 2026

* Correspondence: Xinjuan Kong, kongxinjuan2003@163.com; Shijin Wang, wangshijin1@qdu.edu.cn

†These authors have contributed equally to this work and share first authorship

Copyright © 2026 Zhou, Jing, Zu, Li, Kong and Wang.2026Zhou, Jing, Zu, Li, Kong and Wanghttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. Natural Science Foundation of Shandong Province10.13039/501100007129 The author(s) declared that financial support was received for this work and/or its publication. This work was supported by the Natural Science Foundation of Shandong Province (Grant Number ZR2024QH659).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T00:00:18.311357+00:00

DOI: 10.3389/fendo.2026.1714943 · PMC12956655